A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)
Clinical trial NCT05096403 · COMPLETED
Trial details
- NCT number
- NCT05096403
- Sponsor
- Swedish Orphan Biovitrum
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2024-05-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.